Drug recall · March 25, 2020
Potassium Chloride Extended-Release Tablets USP recall
Why: Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08
- Lots / codes
Lot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021
- Quantity
- 2576 bottles
- Company
- Strides Pharma Science Limited, Bangalore
- Distribution
- U.S.A. Nationwide
- Initiated
- February 17, 2020 · Voluntary: Firm initiated
- Classified
- March 13, 2020
- Reported
- March 25, 2020
- Ended
- February 16, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Potassium chloride
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.